| P2093 | author name string | Hiroyuki Nakamura | |
| | Hidehiro Tajima | |
| | Hironori Hayashi | |
| | Hiroyuki Takamura | |
| | Isamu Makino | |
| | Itasu Ninomiya | |
| | Katsunobu Oyama | |
| | Sachio Fushida | |
| | Seisho Sakai | |
| | Tetsuo Ohta | |
| | Jun Kinoshita | |
| | Keishi Nakamura | |
| | Koichi Okamoto | |
| | Masafumi Inokuchi | |
| | Shinichi Nakanuma | |
| | Tomoharu Miyashita | |
| | Takahisa Yamaguchi | |
| | Atsushi Hirose | |
| | Yoshinao Ohbatake | |
| | Mitsuyoshi Okazaki | |
| | Hiroyuki Shinbashi | |
| P2860 | cites work | Palliative chemotherapy after failure of high-dose chemotherapy in breast cancer--toxicity and efficacy | Q44554071 |
| | Randomized phase III study of gemcitabine plus S-1, S-1 alone, or gemcitabine alone in patients with locally advanced and metastatic pancreatic cancer in Japan and Taiwan: GEST study. | Q45307505 |
| | Weekly docetaxel as salvage therapy in patients with gemcitabine-refractory metastatic pancreatic cancer | Q46448479 |
| | Phase II trial of intravenous flourouracil and subcutaneous interferon alfa-2b for biliary tract cancer | Q50163824 |
| | Paclitaxel coating of the luminal surface of hemodialysis grafts with effective suppression of neointimal hyperplasia. | Q53392106 |
| | Activation of p34cdc2 coincident with taxol-induced apoptosis. | Q53469779 |
| | Epirubicin, cisplatin and infusional 5-fluorouracil (5-FU) (ECF) in hepatobiliary tumours | Q61868335 |
| | The taxoids: paclitaxel and docetaxel | Q72824407 |
| | Paclitaxel as second-line chemotherapy in patients with gemcitabine-refractory pancreatic cancer: a retrospective study | Q83760900 |
| | New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1) | Q28131668 |
| | Phase II study of docetaxel in patients with metastatic pancreatic cancer: a Japanese cooperative study. Cooperative Group of Docetaxel for Pancreatic Cancer in Japan | Q33329495 |
| | Paclitaxel ameliorates fibrosis in hepatic stellate cells via inhibition of TGF-beta/Smad activity | Q33978189 |
| | Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer | Q34618537 |
| | Gemcitabine plus nab-paclitaxel is an active regimen in patients with advanced pancreatic cancer: a phase I/II trial | Q34632818 |
| | Stromal disrupting effects of nab-paclitaxel in pancreatic cancer | Q34654904 |
| | Current management of gallbladder carcinoma | Q35583920 |
| | Paclitaxel decreases the interstitial fluid pressure and improves oxygenation in breast cancers in patients treated with neoadjuvant chemotherapy: clinical implications | Q36073411 |
| | Successful treatment of unresectable gallbladder cancer with low-dose paclitaxel as palliative chemotherapy after failure of gemcitabine and oral S-1: A case report | Q36424359 |
| | Paclitaxel interrupts TGF-beta1 signaling between gallbladder epithelial cells and myofibroblasts | Q36607944 |
| | Low-dose paclitaxel inhibits the induction of epidermal-mesenchymal transition in the human cholangiocarcinoma CCKS-1 cell line | Q39077071 |
| | Adjuvant chemotherapy of S-1 versus gemcitabine for resected pancreatic cancer: a phase 3, open-label, randomised, non-inferiority trial (JASPAC 01). | Q39707839 |
| | Promotion of microtubule assembly in vitro by taxol | Q41461193 |
| | Phase II study of paclitaxel therapy for unresectable biliary tree carcinomas | Q42555316 |
| | Weekly Paclitaxel after failure of gemcitabine in pancreatic cancer patients with malignant ascites: a retrospective study | Q42959222 |
| | Low-dose paclitaxel ameliorates renal fibrosis in rat UUO model by inhibition of TGF-beta/Smad activity | Q43701818 |
| | First-line chemotherapy with docetaxel for unresectable or metastatic carcinoma of the biliary tract. A multicentre phase II study | Q43750756 |
| | A Phase II study of gemcitabine and docetaxel in patients with metastatic pancreatic carcinoma | Q43869761 |
| P433 | issue | 5 | |
| P921 | main subject | paclitaxel | Q423762 |
| P304 | page(s) | 753-757 | |
| P577 | publication date | 2017-03-30 | |
| P1433 | published in | Molecular and Clinical Oncology | Q27725125 |
| P1476 | title | Phase I study of weekly palliative chemotherapy with low-dose third-line paclitaxel for biliary tract cancer | |
| P478 | volume | 6 | |